The company has been a disappointment to the stock market, and third-quarter figures released last month showed a net loss of $23.7 million, up from a loss of $21.8 million on sales down 58.2% at $2.7 million. Cash reserves were $74.4 million, down from $129.4 million at the start of the year.
The company’s future depends on market reception to its new Efficeon processor range that it claims will offer twice the performance of its predecessors at a given clock speed. The share sale is essential to reassure potential customers that it is a supplier they can depend on.
This article was based on material originally published by ComputerWire.